Report Detail
Global Octreotide Market Growth 2019-2024
- RnM2946634 |
- 15 February, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug.
The Octreotide product increased fast in the past five years, the production growth in the past two years. There have been new manufacturers to enter the field year by year. But for now , it is difficult to obtain certification.
It will expect that the production and the capacity will increase fast in the future, But with octreotide acetate in China continues to mature in manufacturing technology, in the future, trade of octreotide API will gradually decrease, more and more Octreotide will sold as finished medicine.
According to this study, over the next five years the Octreotide market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Octreotide business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Octreotide market by product type, application, key manufacturers and key regions and countries.
This study considers the Octreotide value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Treating Severe Diarrhea
Treating Acromegaly
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Octreotide consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Octreotide market by identifying its various subsegments.
Focuses on the key global Octreotide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Octreotide with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Octreotide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Octreotide Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Octreotide Consumption 2014-2024
- 2.1.2 Octreotide Consumption CAGR by Region
- 2.2 Octreotide Segment by Type
- 2.2.1 Octreotide Injection
- 2.2.2 Octreotide Powder
- 2.2.3 Octreotide Microspheres
- 2.3 Octreotide Consumption by Type
- 2.3.1 Global Octreotide Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Octreotide Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Octreotide Sale Price by Type (2014-2019)
- 2.4 Octreotide Segment by Application
- 2.4.1 Treating Severe Diarrhea
- 2.4.2 Treating Acromegaly
- 2.4.3 Others
- 2.5 Octreotide Consumption by Application
- 2.5.1 Global Octreotide Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Octreotide Value and Market Share by Application (2014-2019)
- 2.5.3 Global Octreotide Sale Price by Application (2014-2019)
3 Global Octreotide by Players
- 3.1 Global Octreotide Sales Market Share by Players
- 3.1.1 Global Octreotide Sales by Players (2017-2019)
- 3.1.2 Global Octreotide Sales Market Share by Players (2017-2019)
- 3.2 Global Octreotide Revenue Market Share by Players
- 3.2.1 Global Octreotide Revenue by Players (2017-2019)
- 3.2.2 Global Octreotide Revenue Market Share by Players (2017-2019)
- 3.3 Global Octreotide Sale Price by Players
- 3.4 Global Octreotide Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Octreotide Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Octreotide Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Octreotide by Regions
- 4.1 Octreotide by Regions
- 4.1.1 Global Octreotide Consumption by Regions
- 4.1.2 Global Octreotide Value by Regions
- 4.2 Americas Octreotide Consumption Growth
- 4.3 APAC Octreotide Consumption Growth
- 4.4 Europe Octreotide Consumption Growth
- 4.5 Middle East & Africa Octreotide Consumption Growth
5 Americas
- 5.1 Americas Octreotide Consumption by Countries
- 5.1.1 Americas Octreotide Consumption by Countries (2014-2019)
- 5.1.2 Americas Octreotide Value by Countries (2014-2019)
- 5.2 Americas Octreotide Consumption by Type
- 5.3 Americas Octreotide Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Octreotide Consumption by Countries
- 6.1.1 APAC Octreotide Consumption by Countries (2014-2019)
- 6.1.2 APAC Octreotide Value by Countries (2014-2019)
- 6.2 APAC Octreotide Consumption by Type
- 6.3 APAC Octreotide Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Octreotide by Countries
- 7.1.1 Europe Octreotide Consumption by Countries (2014-2019)
- 7.1.2 Europe Octreotide Value by Countries (2014-2019)
- 7.2 Europe Octreotide Consumption by Type
- 7.3 Europe Octreotide Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Octreotide by Countries
- 8.1.1 Middle East & Africa Octreotide Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Octreotide Value by Countries (2014-2019)
- 8.2 Middle East & Africa Octreotide Consumption by Type
- 8.3 Middle East & Africa Octreotide Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Octreotide Distributors
- 10.3 Octreotide Customer
11 Global Octreotide Market Forecast
- 11.1 Global Octreotide Consumption Forecast (2019-2024)
- 11.2 Global Octreotide Forecast by Regions
- 11.2.1 Global Octreotide Forecast by Regions (2019-2024)
- 11.2.2 Global Octreotide Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Octreotide Forecast by Type
- 11.8 Global Octreotide Forecast by Application
12 Key Players Analysis
- 12.1 Novartis
- 12.1.1 Company Details
- 12.1.2 Octreotide Product Offered
- 12.1.3 Novartis Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novartis News
- 12.2 Sun Pharmaceutical
- 12.2.1 Company Details
- 12.2.2 Octreotide Product Offered
- 12.2.3 Sun Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sun Pharmaceutical News
- 12.3 Chengdu Tiantaishan pharmaceutical
- 12.3.1 Company Details
- 12.3.2 Octreotide Product Offered
- 12.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Chengdu Tiantaishan pharmaceutical News
- 12.4 Sinopharm A-Think Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Octreotide Product Offered
- 12.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Sinopharm A-Think Pharmaceuticals News
- 12.5 Sihuan Pharmaceutical Holdings Group
- 12.5.1 Company Details
- 12.5.2 Octreotide Product Offered
- 12.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Sihuan Pharmaceutical Holdings Group News
- 12.6 Shanghai Soho-Yiming Pharmaceuticals
- 12.6.1 Company Details
- 12.6.2 Octreotide Product Offered
- 12.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Shanghai Soho-Yiming Pharmaceuticals News
- 12.7 Yibin Pharmaceutical
- 12.7.1 Company Details
- 12.7.2 Octreotide Product Offered
- 12.7.3 Yibin Pharmaceutical Octreotide Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Yibin Pharmaceutical News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Octreotide . Industry analysis & Market Report on Octreotide is a syndicated market report, published as Global Octreotide Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Octreotide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
